View Older Stories

Feb 10, 2026 07:00AM Regeneron presents phase 3 data for cat and birch allergy antibody treatments

Feb 9, 2026 07:17AM Regeneron Pharma (REGN) PT Raised to $975 at Guggenheim

Feb 2, 2026 09:25AM BMO Capital on Regeneron Pharma (REGN): 'Commercial Momentum Sets Up 2026'

Feb 2, 2026 07:23AM Regeneron Pharma (REGN) PT Raised to $800 at Cantor Fitzgerald on Commercial Estimates

Feb 2, 2026 07:01AM Regeneron Pharma (REGN) PT Raised to $925 at Bernstein SocGen Group

Feb 2, 2026 07:00AM Regeneron to present EYLEA HD data at Angiogenesis meeting

Feb 2, 2026 05:31AM Regeneron Pharma (REGN) PT Raised to $800 at Wells Fargo

Jan 30, 2026 01:55PM Regeneron Pharma (REGN) PT Raised to $742 at Baird

Jan 30, 2026 09:03AM Regeneron (REGN) Tops Q4 EPS by 92c

Jan 27, 2026 09:00AM Regeneron Pharma (REGN) PT Raised to $916 at Bernstein

Jan 27, 2026 07:12AM RBC Capital Reiterates Sector Perform Rating on Regeneron Pharma (REGN)

Jan 26, 2026 06:42AM BofA Securities on Regeneron Pharma (REGN): 'Updating model for 4Q Eylea and other recent disclosures'

Jan 22, 2026 04:41AM Regeneron Pharma (REGN) PT Raised to $875 at Evercore ISI

Jan 13, 2026 04:52AM Regeneron Pharma (REGN) PT Raised to $820 at Raymond James

Jan 12, 2026 07:16AM Stifel: 'REGN Announcements Validate APGE Thesis'

Jan 8, 2026 08:49AM 4Q25/2026 Biotech Earnings Preview: RBC

Jan 7, 2026 10:43AM Goldman: 'Top Call Buying Opportunities for 2026'

Jan 7, 2026 07:09AM BofA double-upgrades Regeneron, citing stronger Eylea outlook and 2026 catalysts

Jan 7, 2026 06:10AM BofA Securities Double Upgrades Regeneron Pharma (REGN) to Buy

Dec 29, 2025 02:35PM BTIG on Apogee (APGE): 'DUPLEX-AD's Failure is Likely a Clearing Event for APG279 and APG777 in Atopic Dermatitis'

Dec 23, 2025 04:42AM Japan approves Dupixent for children with severe asthma

Dec 19, 2025 02:21PM Trump to announce prescription drug price agreements

Dec 17, 2025 04:03AM Regeneron Pharma (REGN) PT Raised to $873 at Leerink Partners

Dec 9, 2025 08:54AM RBC Capital on Regeneron Pharma (REGN): 'We Continue to Seek a Better Entry Point'

Dec 8, 2025 02:52AM Regeneron reports trial results for Lynozyfic in newly diagnosed myeloma

Dec 4, 2025 08:21AM Regeneron Pharma (REGN) PT Raised to $850 at BMO Capital

Dec 4, 2025 04:12AM Regeneron Pharma (REGN) PT Raised to $1,057 at Canaccord Genuity

Dec 3, 2025 02:19AM Morgan Stanley Downgrades Regeneron Pharma (REGN) to Equalweight

Dec 2, 2025 08:03AM Bernstein Weighs In on Regeneron Pharma (REGN) Following Tessera Deal

Dec 1, 2025 07:09AM Regeneron and Tessera partner on gene editing therapy for rare disease

Nov 25, 2025 03:23AM Dupixent wins EU approval for chronic spontaneous urticaria treatment

Nov 24, 2025 06:46AM Truist Securities Assumes Regeneron Pharma (REGN) at Buy

Nov 24, 2025 03:09AM HSBC Starts Regeneron Pharma (REGN) at Buy

Nov 20, 2025 07:45AM Regeneron Pharma (REGN) Shares Are Almost Back to Positive - Cantor Fitzgerald

Nov 20, 2025 06:58AM Bernstein on Regeneron Pharma (REGN): 'Positive Surprise'

Nov 20, 2025 05:42AM Regeneron Pharma (REGN) PT Raised to $700 at Wells Fargo

Nov 20, 2025 03:40AM Regeneron Pharma (REGN) PT Raised to $800 at Raymond James

Nov 19, 2025 04:46PM After-hours movers: NVIDIA, CoreWeave, Palo Alto Networks, and more

Nov 19, 2025 04:10PM FDA approves EYLEA HD for retinal vein occlusion treatment

Nov 19, 2025 04:05PM Regeneron (REGN) Halted, News Pending

Nov 19, 2025 07:00AM Regeneron gets EU approval for LIBTAYO as adjuvant CSCC treatment

Nov 13, 2025 07:02AM Regeneron presents blood cancer data at ASH hematology conference

Nov 3, 2025 09:09AM Regeneron Pharma (REGN) PT Raised to $725 at BMO Capital

Oct 29, 2025 10:25AM Regeneron Pharma (REGN) PT Raised to $740 at Cantor Fitzgerald

Oct 29, 2025 08:00AM OPKO's ModeX partners with Regeneron on multispecific antibodies

Oct 29, 2025 07:26AM Regeneron Pharma (REGN) PT Raised to $865 at Guggenheim

Oct 29, 2025 05:14AM Regeneron Pharma (REGN) PT Raised to $627 at BofA Securities

Oct 29, 2025 05:12AM Regeneron Pharma (REGN) PT Raised to $630 at Baird

Oct 28, 2025 01:34PM Regeneron Pharma (REGN) PT Raised to $700 at Citi

Oct 28, 2025 06:33AM Regeneron (REGN) Tops Q3 EPS by 219c

View Older Stories